Position in WVE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,523,548
+$3,474,801 QoQ
Shares Held
1,811,282
+86.3% QoQ
Ownership
0.919%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#20
of 237 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in WVE Over Time
Shares Held
Position Value (USD)
Derivatives in WVE
reported options exposure · as of Sep 30, 2025CallValue
$732,000
CallShares
100,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,595,633,334 across 322 Biotechnology names. WVE ranks #104 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in WVE
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,523,548 | 1,811,282 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $7,048,747 | 972,241 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $9,938,761 | 584,633 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $732,000 | 100,000 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $2,860,282 | 390,749 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,500,697 | 692,415 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $211,873 | 26,222 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $14,606,966 | 1,180,838 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,983,653 | 851,665 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $8,304,857 | 1,664,300 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $10,091,713 | 1,635,610 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,598,634 | 514,581 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,465,640 | 254,894 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,771,455 | 761,389 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,185,366 | 1,428,491 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $9,223,396 | 1,317,628 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,012,780 | 557,557 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,493,857 | 1,075,033 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,532,116 | 766,058 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,429,187 | 1,092,098 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,301,133 | 1,081,864 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $820,512 | 123,200 | Call | Sole | 2021-08-16 | |
| 2021-06-30 | $7,575,949 | 1,137,530 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,084,014 | 371,482 | Shares | Sole | 2021-05-17 | |
| 2021-03-31 | $280,500 | 50,000 | Call | Sole | 2021-05-17 | |
| 2020-12-31 | $914,006 | 116,138 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $124,403 | 14,653 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,284,458 | 123,387 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||